Recruiting
Phase 2

Trilaciclib & Lurbinectidin

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT05578326

Conditions

Lung Cancer

Small-cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Trilaciclib

Lurbinectedin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-29. This information was provided to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center on 2024-06-28.